Dr Martens said trading so far this year has been in line with expectations.
In a trading update ahead of its AGM today, the shoemaker said its direct-to-consumer (DTC) business has seen good growth across both the EMEA and APAC regions, with strength in retail post-pandemic and good e-commerce growth.
However, wholesale revenues were down year-on-year due to a decision to reduce EMEA retailer supply and the ending of sales to a Chinese distributor, it said.
Sales in the Americas were also down compared to the previous year, although Dr Martens said that this was in line with expectations.
Dr Martens added that it is taking actions to progress its DTC business in the Americas, and expects to see “meaningful” improvement in the second half.